Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.
about
Cerebral malaria: mysteries at the blood-brain barrierDeficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injuryCerebral malaria: gamma-interferon reduxCD36 and Fyn kinase mediate malaria-induced lung endothelial barrier dysfunction in mice infected with Plasmodium bergheiNeuroimmunological blood brain barrier opening in experimental cerebral malariaParasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model.CD8(+)-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice.IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malariaOrthology between the genomes of Plasmodium falciparum and rodent malaria parasites: possible practical applications.Multivariate modelling with (1)H NMR of pleural effusion in murine cerebral malariaEndothelial focal adhesions and barrier function.Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria.Protection against cerebral malaria by the low-molecular-weight thiol pantethine.Integrin αDβ2 (CD11d/CD18) mediates experimental malaria-associated acute respiratory distress syndrome (MA-ARDS).The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria.Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.Artesunate Exerts a Direct Effect on Endothelial Cell Activation and NF-κB Translocation in a Mechanism Independent of Plasmodium KillingComparative effects of vasopressin, norepinephrine, and L-canavanine, a selective inhibitor of inducible nitric oxide synthase, in endotoxic shock.Co-infection with Chikungunya virus alters trafficking of pathogenic CD8(+) T cells into the brain and prevents Plasmodium-induced neuropathology.Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria.Protection from experimental cerebral malaria with a single intravenous or subcutaneous whole-parasite immunization.Could Heme Oxygenase-1 Be a New Target for Therapeutic Intervention in Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome?Cerebral Malaria in Mouse and Man
P2860
Q21032533-19C2B45A-0658-4682-BF12-9AFDB4A1773FQ24791922-812F4FB9-0467-4354-BF9A-5B0FF731B721Q26824074-335C48CD-570A-4862-BA57-9D37C179C2D9Q27309911-43FFC223-D74A-40B1-BBA7-E6C495ECE90AQ27341951-24446978-72B3-41D7-979C-7C814045BAF3Q33335133-0A9807E2-A896-4F58-B7C8-684BF6601703Q34009605-7B3373BD-A578-4AA4-A30A-C3D2F27C272AQ35187600-AEB30080-4717-4762-BBE2-FD41F08409B6Q35212991-4689B547-D633-4709-BDED-5C6735F1CD7EQ35586924-7DB124BF-FD54-48F3-9CD7-229766F469AAQ36272883-6BAEB46B-30BE-4FBF-A871-9693908BE429Q36376492-7C86AEE1-1254-4555-9C58-20BFB165F334Q36446215-B6972475-309F-456B-9D0F-A7269D9A321CQ37139922-D84F8427-2B74-4985-BCD7-ECF1AEA04CDCQ37633868-2FB85D37-E447-49B2-9402-106AA3A757F4Q40120742-AC1C3572-4BEF-405B-A539-687F260067F2Q40558730-03A44301-B5F9-4B8F-B175-AE8F037E758CQ42410932-2D596948-A3BB-47D1-82CF-4BFE14094F60Q44779143-8B387FB5-DDD8-4CB8-9C9D-69C299BB4AB2Q44843600-7FDAC9E7-6718-4011-9CF9-52938FEE2676Q45997398-0A9C770A-96E3-4EBC-9AE6-D1EAD52216C4Q49958400-13346C6F-A22F-4E25-88A0-20ED4A1DF2A2Q55434398-7A2F8A38-37E7-47DA-9B3F-7F9043FC8D04Q58754437-A0E68A23-B008-497A-BA34-6A7C5CB2E659
P2860
Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Assessing vascular permeabilit ...... monoclonal antibody technique.
@ast
Assessing vascular permeabilit ...... monoclonal antibody technique.
@en
Assessing vascular permeabilit ...... monoclonal antibody technique.
@nl
type
label
Assessing vascular permeabilit ...... monoclonal antibody technique.
@ast
Assessing vascular permeabilit ...... monoclonal antibody technique.
@en
Assessing vascular permeabilit ...... monoclonal antibody technique.
@nl
prefLabel
Assessing vascular permeabilit ...... monoclonal antibody technique.
@ast
Assessing vascular permeabilit ...... monoclonal antibody technique.
@en
Assessing vascular permeabilit ...... monoclonal antibody technique.
@nl
P2093
P2860
P921
P1476
Assessing vascular permeabilit ...... monoclonal antibody technique.
@en
P2093
D N Granger
H C van der Heyde
P2860
P304
P356
10.1128/IAI.69.5.3460-3465.2001
P407
P577
2001-05-01T00:00:00Z